Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]

Abstract

David M Williams,1 Jeffrey W Stephens1,2 1Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 8NL, UK; 2Diabetes Research Group, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UKCorrespondence: David M Williams, Diabetes Centre, Morriston Hospital, Swansea, SA6 6NL, UK, Tel [phone], Email [email protected] View the original paper by Dr Williams and colleagues This is in response to the Letter to the Editor

Keywords

• genetic polymorphism type 2 diabetes
• drug metabolism
• transporter
• precision medicine